| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -50,332 | -68,919 | -61,334 | -66,719 |
| Earnings per share, basic, total | -0.45 | -0.62 | -0.56 | -0.71 |
| Earnings per share, diluted, total | -0.45 | -0.62 | -0.56 | -0.71 |
| Weighted average number of shares outstanding, basic, total | 111,571,136 | 111,019,647 | 110,093,461 | 94,158,491 |
| Weighted average number of shares outstanding, diluted, total | 111,571,136 | 111,019,647 | 110,093,461 | 94,158,491 |
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)